News and events

Press releases

Data demonstrating that SEPREHVIR (VIRTTU BIOLOGICS) combines syergistically with Anti-PD-1 Immune Checkpoint Inhibitor to be presented at AACR's Advances in Pediatric Cancer Research

Date: 09/11/2015

Read more

Posters and talks

Immune responses following intrapleural administration of the oncolytic HSV SEPREHVIR in patients with malignant pleural mesothelioma

Conference: 14th Annual CIMT Meeting (Cancer Immunotherapy), 11/05/2016

Presenter(s): Kirsty Learmonth, Lynne Braidwood, Penella Woll, Chelsea Bolyard, Balveen Kaur, Kevin Blyth and Joe Conner

Download PDF: CIMT 2016 MPM print Read more

Conferences and events

Date: 19/04/2016

VIRTTU will present at Biotrinity in London on Tuesday, April 26, 2016.

Details of VIRTTU’s presentation are as follows:


BioTrinity 2016


April 26, 2016


11.30 p.m. GMT


Lalande/Talbot room, 2nd floor Novotel London West

Read more

Recent papers

Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility

Author(s): Wang PY, Swain HM, Kunkler AL, Chen CY, Hutzen BJ, Arnold MA, Streby KA, Collins MH, Dipasquale B, Stanek JR, Conner J, van Kuppevelt TH, Glorioso JC, Grandi P, Cripe TP

Reference: Gene Ther. 2015 Nov 19. doi: 10.1038/gt.2015.105.

Read more